News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
678,790 Results
Type
Article (38772)
Company Profile (247)
Press Release (639771)
Section
Business (203500)
Career Advice (1977)
Deals (35343)
Drug Delivery (78)
Drug Development (80604)
Employer Resources (167)
FDA (16011)
Job Trends (14778)
News (343664)
Policy (32406)
Tag
Academia (2528)
Africa (710)
Alliances (48966)
Alzheimer's disease (1139)
Approvals (15932)
Arizona (174)
Artificial intelligence (69)
Asia (36789)
Australia (5981)
Bankruptcy (350)
Best Places to Work (11268)
Biosimilars (63)
Biotechnology (175)
C2C Services and Suppliers (78792)
California (1824)
Canada (916)
Cancer (466)
Career advice (1647)
Cell therapy (116)
China (145)
Clinical research (63171)
Collaboration (133)
Colorado (71)
Compensation (80)
Connecticut (70)
COVID-19 (2486)
Cystic fibrosis (72)
Data (289)
Diabetes (81)
Diagnostics (5967)
Drug pricing (61)
Earnings (83640)
Employer resources (142)
Europe (78579)
Events (107757)
Executive appointments (142)
FDA (16216)
Florida (258)
Funding (141)
Gene therapy (88)
GLP-1 (507)
Government (4288)
Healthcare (18604)
Hotbed/Location (480947)
Illinois (251)
Indiana (145)
Infectious disease (2513)
Inflammatory bowel disease (90)
Interviews (306)
IPO (16190)
Job creations (3618)
Job search strategy (1412)
Kansas (94)
Layoffs (393)
Legal (7828)
Lung cancer (109)
Manufacturing (83)
Maryland (385)
Massachusetts (1486)
Medical device (13036)
Medtech (13041)
Mergers & acquisitions (19004)
Metabolic disorders (243)
Michigan (123)
Minnesota (213)
Neuroscience (1278)
New Jersey (562)
New York (572)
NextGen Class of 2024 (6479)
Non-profit (4455)
North Carolina (581)
Northern California (814)
Obesity (144)
Ohio (104)
Opinion (171)
Patents (67)
Pennsylvania (569)
People (55818)
Pharmaceutical (60)
Phase I (19568)
Phase II (27820)
Phase III (20792)
Pipeline (107)
Postmarket research (2546)
Preclinical (8306)
Press Release (64)
Rare diseases (127)
Real estate (5880)
Recruiting (63)
Regulatory (21176)
Research institute (2304)
Resumes & cover letters (346)
South America (1085)
Southern California (738)
Startups (3557)
Texas (234)
United States (8343)
Vaccines (469)
Washington State (246)
Weight loss (125)
Date
Today (70)
Last 7 days (672)
Last 30 days (2270)
Last 365 days (37227)
2024 (25889)
2023 (40074)
2022 (51173)
2021 (55713)
2020 (54087)
2019 (46541)
2018 (35020)
2017 (32111)
2016 (31481)
2015 (37552)
2014 (31318)
2013 (26346)
2012 (28571)
2011 (29263)
2010 (27328)
678,790 Results for "penumbra inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Penumbra, Inc. to Present at the Truist Securities MedTech Conference 2024
Penumbra, Inc. announced that its management team is scheduled to present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024.
June 4, 2024
·
1 min read
Biotech Bay
Penumbra, Inc. to Present at the William Blair Growth Stock Conference
Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the William Blair Growth Stock Conference on Thursday, June 6, 2024.
May 23, 2024
·
1 min read
Business
Penumbra, Inc. Reports First Quarter 2024 Financial Results
Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the first quarter ended March 31, 2024.
May 7, 2024
·
15 min read
Biotech Bay
Penumbra, Inc. to Present at the RBC Capital Markets Global Healthcare Conference
Penumbra, Inc. announced that its management team is scheduled to present at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 15, 2024.
May 1, 2024
·
1 min read
Business
Penumbra, Inc. to Present at the Baird Global Healthcare Conference
August 27, 2024
·
1 min read
Business
Penumbra, Inc. to Present at the Wells Fargo Healthcare Conference
August 22, 2024
·
1 min read
Press Releases
Penumbra, Inc. Announces $200 Million Share Repurchase Authorization
August 13, 2024
·
4 min read
Business
Penumbra, Inc. to Present at the Canaccord Genuity Growth Conference
August 5, 2024
·
1 min read
Business
Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024
Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2024 after market close on Tuesday, May 7, 2024 at 4:30 PM Eastern Time.
April 9, 2024
·
1 min read
Business
Penumbra, Inc. Reports Second Quarter 2024 Financial Results
July 30, 2024
·
21 min read
1 of 67,879
Next
